Back to stories
Industry

Fractile raises $220M Series B as Anthropic eyes UK in-memory inference chips

Michael Ouroumis2 min read
Fractile raises $220M Series B as Anthropic eyes UK in-memory inference chips

Fractile, a London-based AI chip startup, has closed a $220 million Series B led by Accel, Factorial Funds and Peter Thiel's Founders Fund, with Conviction, Felicis and 8VC also participating alongside existing seed backers Kindred Capital, the NATO Innovation Fund and Oxford Science Enterprises. Former Intel CEO Pat Gelsinger joined as an angel investor and operating adviser. The round reportedly values the company at roughly $1 billion post-money, its first formal entry into the unicorn bracket — and it lands as Anthropic is reported to be in early discussions to buy Fractile silicon once it ships.

In-memory compute, not another GPU clone

Fractile's pitch is architectural, not a packaging tweak. The company designs inference parts that perform matrix multiplications directly inside SRAM cells alongside the compute logic, eliminating most of the data movement between DRAM and tensor cores that dominates power and latency budgets on current accelerators. Investor materials cite up to 25x faster inference at roughly 10% of the operating cost of comparable GPU deployments. Earlier company decks pitched a 100x speedup and 10x cost reduction; the more recent number set is the one running in front of customers.

The first commercial part is targeted for 2027. That timeline matters: it places Fractile in the same window as Nvidia's Vera Rubin successor generation and the next round of custom silicon from Broadcom-Google, MediaTek-Meta and Marvell-Amazon.

The Anthropic angle

Anthropic's diligence on Fractile is the more consequential signal in the deal. Anthropic already runs Claude across three back-ends — Nvidia GPUs, Google TPUs, and AWS Trainium/Inferentia — and has publicly described compute diversification as a structural priority. Adding Fractile would make it a fourth supplier, and the first non-hyperscaler, non-Nvidia line in the mix. For an inference-heavy workload at Anthropic's scale, a 10x cost-per-token reduction is a multi-billion-dollar lever even at modest adoption.

For builders, the implication is narrower but worth tracking: a credible third architectural category for inference (alongside GPUs and TPU-style systolic arrays) means the cheapest tokens per dollar in 2027 may not run on hardware that today's serving stacks are tuned for.

What's actually shipping

Nothing, yet. Fractile is pre-revenue and pre-silicon at volume. The $220 million is Series B capital to tape out, qualify and pilot — not the Series C that funds a fleet. Founder Walter Goodwin, an Oxford Robotics Institute PhD in his late twenties, leads a team split between London and Bristol.

The round is also a vote on European silicon as a category. With Sarvam, Mistral, Nebius, Nscale and now Fractile pulling growth-stage capital this quarter, the assumption that frontier-scale inference infrastructure has to be designed and operated from the US is getting actively tested with real money.

Learn AI for Free — FreeAcademy.ai

Take "AI for Business: Practical Implementation" — a free course with certificate to master the skills behind this story.

More in Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI
Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI

At I/O 2026, Google relaunched Antigravity as a standalone agent-orchestration platform with a CLI that replaces the Gemini CLI, an SDK, Managed Agents in the Gemini API, and an enterprise tier — all defaulting to Gemini 3.5 Flash.

10 min ago2 min read
Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max
Industry

Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max

Alibaba's chip unit T-Head unveiled the Zhenwu M890 AI accelerator, claiming 3x the agentic-inference performance of Nvidia's H20 and 144GB of HBM3, paired with the Qwen 3.7-Max model — a full domestic stack as US export controls tighten.

1 hours ago2 min read
Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents
Industry

Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents

Cohere has acquired Montréal- and Berlin-based biopharma startup Reliant AI, folding its automated research workbench into the North platform to launch 'North for Pharma' — its second acquisition in a month as it doubles down on sovereign, regulated-industry AI.

3 hours ago2 min read